Extraordinary General Meeting of Shareholders of InterCure Ltd.roman4682Nov 4, 20240 min readUpdated: Feb 2704-11-2024.pdfDownload PDF • 122KB
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million